Clinical trials
Completed Rectal Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht Radiation Oncology | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Maastricht University Medical Center | 3 |
| University Medical Center Groningen | 2 |
| Amgen | 1 |
| Bordeaux Colorectal Institute Academy | 1 |
| Dutch Colorectal Cancer Group | 1 |
| Fresenius Kabi | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 27 |
| Colorectal Neoplasms | 8 |
| Colonic Neoplasms | 7 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.